FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorCharles Kamen
About this trial
Our aim for this study is to assess the feasibility and acceptability and explore potential outcomes of the adapted FOCUS On Us intervention in a two-arm pilot trial. The investigators will randomize 80 sexual and/or gender minority (SGM; e.g., lesbian, gay, bisexual, transgender, queer, etc.) cancer patients and their ≥80 informal caregivers (total N≥160) to either FOCUS On Us (adapted from the evidence-based FOCUS program) or a waitlist control.
Eligibility criteria
Qualifiers
have been diagnosed or had a biochemical recurrence or progression of any invasive (e.g., Stage ≥1) cancer within the past 24 months;
have at least one informal (unpaid) caregiver willing to participate in the program;
identify as a sexual and/or gender minority (SGM) OR have a caregiver who identifies as SGM (e.g., either the patient or caregiver(s) must be SGM);
be age 18 or older;
Disqualifiers
None
Trial design
Treatments tested in this trial
- FOCUS ON US
Treatment groups
160 Participants
are divided into 2 treatment groupsLocations
2Wayne State University48202, DetroitMichigan, United States
University Of Rochester14642, RochesterNew York, United States
Sponsors and collaborators
Charles Kamen
Lead sponsor
University of Rochester
Sponsor institution
Wayne State University
Collaborator
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov